LUVERIS
LUVERIS
Approved
DIN Number
02269066
Drug Class
Human
Market Date
Jun 28, 2005
Company
HC
emd serono, a division of emd inc., canada
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02269066
AIG Number0151221001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
G03GA07 LUTROPIN ALFA
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationSubcutaneous
AHFS Classification68:18.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
LUTROPIN ALFAActive
Strength: 75 UNIT / VIAL
Monograph: LUTROPIN ALFA